La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Zhejiang Wolwo Bio-Pharmaceutical Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Zhejiang Wolwo Bio-Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥49.2M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥2.6B and CN¥241.2M respectively. Zhejiang Wolwo Bio-Pharmaceutical's EBIT is CN¥315.0M making its interest coverage ratio -10.5. It has cash and short-term investments of CN¥1.3B.
Informazioni chiave
2.1%
Rapporto debito/patrimonio netto
CN¥49.17m
Debito
| Indice di copertura degli interessi | -10.5x |
| Contanti | CN¥1.28b |
| Patrimonio netto | CN¥2.38b |
| Totale passività | CN¥241.17m |
| Totale attività | CN¥2.62b |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185
Jun 30
Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking
May 27Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)
May 07Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?
Mar 22Analisi della posizione finanziaria
Passività a breve termine: 300357's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥161.9M).
Passività a lungo termine: 300357's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥79.3M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 300357 has more cash than its total debt.
Riduzione del debito: 300357's debt to equity ratio has increased from 0% to 2.1% over the past 5 years.
Copertura del debito: 300357's debt is well covered by operating cash flow (695.4%).
Copertura degli interessi: 300357 earns more interest than it pays, so coverage of interest payments is not a concern.